(Applicant's Description) The Vanderbilt Cancer Center is a comprehensive, multidisciplinary clinical and laboratory research center. The Vanderbilt Cancer Center integrates the cancer-related expertise and resources of the School of Medicine, Vanderbilt University Hospital, and the Vanderbilt Clinic within the Vanderbilt Univer- sity Medical Center; the fully integrated Veterans Administration (VA) Medical Center and the Departments of Chemistry and Molecular Biology in the School of Arts and Sciences. All facilities are located in close proximity on the same campus, a situation which promotes interactions, sharing of resources and collaborations. Established in 1993, the Vanderbilt Cancer Center functions as an organizational unit with a supradepartmental status. The Vanderbilt Cancer Center's specific authorities and responsibilities are: (1) To coordinate and integrate the cancer and cancer-related activities of Vanderbilt University. (2) To conduct, support and enhance cancer research and to integrate cancer-related research throughout the University. (3) To integrate, develop, and conduct cancer education programs. (4) To coordinate and integrate the care of cancer patients at Vanderbilt University Medical Center and the Veterans Administration Medical Center. The research objectives are accomplished through eight research programs and nine shared resources: Programs: (1) Signal Transduction, (2) Regulation of Cell Proliferation, (3) Gastrointestinal Cancer, (4) Cancer Etiology, (5) Cancer Genetics, (6) Breast Cancer, (7) Cancer Pharmacology, (8) Clinical Investigations; Shared Resources: (1) Biostatistics/Data Management, (2) Bioanalytical, (3) Cell Imaging, (4) DNA Sequencing, (5) Genetics, (6) Peptide Sequencing and Amino Acid Analysis, (7) Transgenic Mouse/ES Cell, (8) Human Tissue Acquisition and Pathology, and (9) Viral Vector. Integration of all cancer-related activities under the authority of the Vanderbilt Cancer Center provides an effective administrative structure to promote novel interactive approaches to cancer research, and partial support for this research infrastructure is requested in this application for a Cancer Center Support Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA068485-03S1
Application #
2859161
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Bhorjee, Jaswant
Project Start
1998-09-01
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications